about
PDX1 associated therapy in translational medicineSIRT3 and cancer: tumor promoter or suppressor?Reconsideration of in-silico siRNA design based on feature selection: a cross-platform data integration perspectiveLocal applications of myostatin-siRNA with atelocollagen increase skeletal muscle mass and recovery of muscle functionTargeting fungal genes by diced siRNAs: a rapid tool to decipher gene function in Aspergillus nidulansAnti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cellsGenomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.Lack of correlation between predicted and actual off-target effects of short-interfering RNAs targeting the human papillomavirus type 16 E7 oncogene.N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA deliveryTargeting Six1 by lentivirus-mediated RNA interference inhibits colorectal cancer cell growth and invasion.Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.Applications and potential toxicity of magnetic iron oxide nanoparticles.Effectiveness of cationic liposome-mediated local delivery of myostatin-targeting small interfering RNA in vivo.Advances, nuances, and potential pitfalls when exploiting the therapeutic potential of RNA interference.Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells.Pancreatic cancer actionable genes in precision medicine and personalized surgery.RNAi-mediated gene silencing of vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of gastric cancer in vivo in mice.Epigenetic therapies - a new direction in clinical medicine.MicroRNA in Myelopoiesis and Myeloid Disorders
P2860
Q26744079-0AD1E1F0-D8F9-4739-8B43-F24A44080912Q28390097-166413C3-CD8B-4AC0-8BED-2D41CD78AD92Q28483920-B3EF08F0-727A-4BE1-82C0-20F09F9274F6Q34746296-B5D386AF-B12F-4619-B675-D415D45699C3Q35018283-E4A8578C-46DE-4EB3-9275-0F077993C708Q35144394-FDFB37DB-69D6-4648-98F5-320E8CD8801FQ36144711-51D8C30F-36C1-46F6-9D79-B4374E2EC551Q36594145-E6970796-8076-4568-93A6-7A015DDF20ABQ37137333-2FC9B7CB-CF08-482D-B122-8149013A5F6EQ37587365-D9456EA6-F0EE-43DA-A434-BC6AA1BF0E67Q38028961-244F9257-3C2E-4856-BC69-4FFE88589A20Q38047272-B8079940-0E9E-4259-94F8-AD194F2A21BCQ38308447-19AB662D-762C-432C-A5C6-543EC6071BBDQ38351487-6B3CC678-A365-4779-B8FC-46A93E9E76EFQ38756973-4532DCEE-7809-49B8-80E0-629AA867D42BQ38884916-F2B22422-5E94-439D-875C-C84875CC6ED5Q46203603-CEFFCB5E-EC4E-4E9C-9C08-7FBD95D1B870Q51733858-B9DC70B2-38D2-4BD1-BA3D-0629F4775F3BQ57589030-2FCC6DB5-92AE-4F18-BE37-7F0424324B97
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potential use of RNA interference in cancer therapy.
@en
Potential use of RNA interference in cancer therapy.
@nl
type
label
Potential use of RNA interference in cancer therapy.
@en
Potential use of RNA interference in cancer therapy.
@nl
prefLabel
Potential use of RNA interference in cancer therapy.
@en
Potential use of RNA interference in cancer therapy.
@nl
P2093
P2860
P1476
Potential use of RNA interference in cancer therapy.
@en
P2093
Connor Phalon
Donald D Rao
John Nemunaitis
P2860
P356
10.1017/S1462399410001584
P577
2010-08-18T00:00:00Z